Dual Purpose Vectors for Rare Neurological Diseases: Molecular Therapy
Por um escritor misterioso
Descrição
Biomolecules, Free Full-Text
Antioxidants, Free Full-Text
Clinical Development of Gene Therapies: The First Three Decades and Counting - ScienceDirect
Nanodiamond Integration into Niosomes as an Emerging and Efficient Gene Therapy Nanoplatform for Central Nervous System Diseases
JPM, Free Full-Text
Frontiers Delivering gene therapy for mucopolysaccharide diseases
Therapeutic potential of gene therapy for gastrointestinal diseases: Advancements and future perspectives - ScienceDirect
Adeno-associated viral vectors for functional intravenous gene transfer throughout the non-human primate brain
Coave Therapeutics – Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare ocular and CNS (Central Nervous System) diseases.
Current Clinical Applications of In Vivo Gene Therapy with AAVs: Molecular Therapy
Intranasal delivery of mesenchymal stem cells‐derived extracellular vesicles for the treatment of neurological diseases - Herman - 2021 - STEM CELLS - Wiley Online Library
Durability of transgene expression after rAAV gene therapy: Molecular Therapy
